痴呆老年人潜在不适当用药:移民背景是否有影响?
荷兰一项基于电子健康记录的队列研究纳入9055名社区痴呆老年人,其中294人有非西方移民背景。调整随访时间、年龄、性别和处方总数后,非西方移民背景者痴呆特异性潜在不适当用药处方率低于无移民背景者(30.6% vs 34.4%,OR 0.71,95%CI 0.54-0.92),苯二氮䓬类处方尤其更少(15.0% vs 19.3%,OR 0.61,95%CI 0.43-0.84)。
要点
- 非西方移民背景痴呆老人PIM处方率低于无移民背景者(OR 0.71)。
- 苯二氮䓬类处方差异更明显(15.0% vs 19.3%,OR 0.61)。
- 痴呆病程、独居、收入、城市化程度不影响上述关联。
核心结论
- 荷兰社区痴呆老年人中,非西方移民背景者痴呆特异性PIM处方率低于无移民背景者。
- 该差异反映更优照护质量、更高专业不确定性还是对心理健康问题识别不足,尚需进一步研究。
研究设计与样本
- 队列研究,链接全科医生电子健康记录与荷兰统计局登记数据(2013-2014年)。
- 共纳入9055名社区痴呆老年人,其中294人根据出生国定义为非洲、南美或亚洲的非西方移民背景。
- 采用逻辑回归分析,调整随访时间、年龄、登记性别和处方总数,并检验潜在相关协变量的交互效应。
主要发现
- 非西方移民背景者痴呆特异性PIM处方率为30.6%,无移民背景者为34.4%(OR 0.71,95%CI 0.54-0.92)。
- 非西方移民背景者苯二氮䓬类处方率为15.0%,无移民背景者为19.3%(OR 0.61,95%CI 0.43-0.84)。
- 痴呆病程、独居、家庭收入和城市化程度未影响上述关联。
关键数值与推荐
- 痴呆特异性PIM处方:非西方移民背景30.6% vs 无移民背景34.4%,OR 0.71(95%CI 0.54-0.92)。
- 苯二氮䓬类处方:非西方移民背景15.0% vs 无移民背景19.3%,OR 0.61(95%CI 0.43-0.84)。
临床怎么用
- 对痴呆老年人评估PIM时,可关注移民背景差异,但不宜据此直接推断照护质量优劣。
- 非西方移民背景痴呆老人苯二氮䓬类处方更少,需结合临床情境判断是否为合理减量或识别不足。
局限性
- 原文未明确报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Previous research in the general population shows more potentially inappropriate medications (PIMs) among persons with a migration background compared with persons without a migration background. This study investigated the association between non-Western (nw) migration background (MB) and dementia-specific PIMs in older adults with dementia in the Netherlands. DESIGN: Cohort study using routinely recorded electronic health records and administrative data. SETTING AND PARTICIPANTS: Electronic health record data of general practitioners from the NIVEL-Primary Care Database, were linked to registries managed by Statistics Netherlands (2013-2014). A total of 9055 community-dwelling older adults with dementia were included, among whom 294 persons had an nw-MB from Africa, South America, or Asia, based on their country of birth. METHODS: We determined the presence of dementia-specific PIM prescriptions and compared this between persons with an nw-MB and without an MB, using logistic regression analysis adjusted for follow-up time, age, registered sex, and total number of prescriptions. Interaction effects of potentially relevant covariates were tested. The 3 largest nw-MB groups in the Netherlands were analyzed separately. RESULTS: Dementia-specific PIMs were less frequently prescribed to persons with an nw-MB compared to persons without an MB with a dementia diagnosis [30.6% vs 34.4%, odds ratio (OR) 0.71, 95% CI 0.54-0.92], with especially less often a benzodiazepine prescription in the group with an nw-MB, compared to persons without an MB (15.0% vs 19.3%, OR 0.61, 95% CI 0.43-0.84). Dementia duration, living alone, household income, and degree of urbanization did not influence the associations. CONCLUSIONS AND IMPLICATIONS: Among older adults with dementia in the Netherlands, persons with an nw-MB had less often a dementia-specific PIM prescription compared to persons without an MB. Whether this difference is a reflection of better quality of care, higher professional uncertainty, or less recognition of (mental) health problems in persons with an nw-MB and dementia, needs further investigation.
引用
- Strooij BT, Blom MT, van Hout HPJ, et al. Potentially Inappropriate Medication in Older Persons With Dementia: Does a Migration Background Matter? J Am Med Dir Assoc. 2024. PMID: 39009066. doi:10.1016/j.jamda.2024.105150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。